Dr. Andrew Round, Senior Investment Director at Deepbridge, is set to bring his extensive experience in healthcare and life science investments to an upcoming beauty and wellness industry event. This event, supported by Frankie’s, an exclusive membership network dedicated to empowering businesswomen in finance, will offer attendees unique opportunities to connect, collaborate, and enhance their financial knowledge.
One of Deepbridge's Technology Growth EIS Companies, HeadBox, Named Finalists for Agency of the Year at miaList 2024
HeadBox, a company supported by Deepbridge’s Technology Growth Enterprise Investment Scheme (EIS), has been shortlisted as a finalist in the Agency of the Year award category for the miaList 2024. This is a significant achievement for the company, which has been making waves in the meetings and events industry with its unique approach.
FluoretiQ, which is part of the Deepbridge Life Sciences EIS portfolio, is excited to share that their European patent for SCFI has been granted!
Deepbridge Capital is a finalist for an award at the upcoming Growth Investor 2024 Awards, taking place 21st November at the London Hilton, Park Lane.
